About Biostate AI
Biostate AI is a Healthcare company based in Houston (United States) founded in 2023 by Ashwin Gopinath and David Zhang. Future omics states are predicted by generative AI-based RNAstate platform. Biostate AI has raised $16 million across 2 funding rounds from investors including Caltech, Accel and Matter Venture Partners. Its chief executive, as recorded, is David Zhang. Biostate AI offers products and services including Total RNASeq, mRNA Sequencing, and Data Analysis. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is BIOSTATE AI, INCORPORATED. Its competitors include Cellworks, Genuity Science and Codetta; 3 of its 3 listed competitors have raised funding.
Company details
Biostate was founded in 2023 in Houston, United States, as a developer of a generative AI platform focused on RNAstate research for bioinformatics. Temporal precision in predicting omics states is enabled through analytics, insights, and visualizations. Barcode-integrated reverse transcription is utilized to analyze RNA types, including non-coding species. Gene expression and regulation are examined via RNA sequencing tools, supporting insights into disease mechanisms and therapeutic targets for research organizations.
- Headquarters Houston, United States
- Founders Ashwin Gopinath, David Zhang
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biostate.ai
- Social LinkedIn X Facebook Instagram
- Legal Name Biostate Ai, Incorporated
- Total Equity Funding$16M (USD)
in 2 rounds
- Latest Funding Round$12M (USD), Series A
Apr 2025
- InvestorsCaltech
& 10 more
Products & Services of Biostate AI
Biostate AI offers a comprehensive portfolio of products and services, including Total RNASeq, mRNA Sequencing, and Data Analysis.
Sequences total RNA from samples for scientific insights.
Analyzes mRNA for gene expression studies in research.
Provides end-to-end data processing for RNA sequencing results.
Funding Insights of Biostate AI
Biostate AI has successfully raised a total of $16M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16M
- Total Rounds 2
- Last Round Series A — $12M
- First Round $4M
(Jul 2024)
- Investors Count 11
All 2 funding rounds of Biostate AI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $12M | Series A | – | Accel | |
| Jul 2024 | $4M | Seed | – | – |
11 investors in total: 7 institutional and 4 angel.
Investors in Biostate AI
Biostate AI has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Caltech, Accel and Matter Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Matter Venture Partners is focused on funding HardTech startups. | mattervp.com | Silicon Valley, United States | ||
Venture capital fund focused on multiple sectors | visionpluscapital.com | Hangzhou, China | ||
Catapult is recognized as a global seed stage venture capital platform. | catapultvc.com | Palo Alto, United States | ||
Accel is recognized as a leading venture capital firm. | 1983 | accel.com | Palo Alto, United States | |
Venture capital investing with a focus on diversity and inclusion in the ecosystem. | gaingels.com | |||
Investments in early-stage tech firms and consumer brands are made. | manaventures.vc | San Francisco, United States | ||
Higher education and research in science and engineering are offered. | 1891 | caltech.edu | United States | |
DA Dario Amodei | CEO of Anthropic, AI researcher, angel investor in tech startups | unknown_6b6fbb2ad84c443aa | ||
JP Joris Poort | Founder of Rescale, active angel investor in tech startups | unknown_f42c19376a7f4cd5b | ||
EL Emily Leproust | CEO of Twist Bioscience, pioneering synthetic biology, active angel investor | unknown_071c9b5ecf8f4caeb |
Investor details for Biostate AI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biostate AI
5 people are tracked at Biostate AI (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Ashwin Gopinath | Co-Founder & CTO | Leadership |
David Zhang | Co-Founder & CEO | Leadership |
Nicolas Garreau de Loubresse | Head Of Business Development & Partnerships | Leadership |
Kristina Beaman | Operations Manager | Team |
Christopher Yasso | Strategic Partnerships Lead | Team |
Complete people profiles for Biostate AI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biostate AI
3 dated milestones of Biostate AI across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Biostate AI is founded.
- Funding First funding round of $4.0M.
- Funding Latest funding round, Series A, of $12.0M.
Competitors of Biostate AI
Biostate AI has 3 listed competitors in our database, 3 of them funded. They include Cellworks, Genuity Science and Codetta.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellworks.life | 2005 | San Jose, United States | $16.52M | Biosimulation platform developed for therapeutic design in life sciences. | ||
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. | ||
| codettabio.com | 2021 | Morrisville, United States | $27.28M | Omics clinical data is analyzed through an online platform. |
Detailed competitors of Biostate AI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biostate AI
The website of Biostate AI (biostate.ai) receives about 10K visits a month.
- Monthly visits10K
▼ 47.4% vs previous month
Websites whose visitors overlap most with Biostate AI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
brukerspatialbiology.com | brukerspatialbiology.com | 100% | #1,916,880 | – | |
| lcsciences.com | 99% | #2,732,434 | View details | ||
stanforddaily.com | stanforddaily.com | 35% | #161,837 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Biostate AI (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biostate Ai
Complete news archive for Biostate AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biostate AI
Biostate AI was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Biostate AI is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
David Zhang is the CEO of Biostate AI, as recorded in our data. They have also founded this company.
Biostate AI is a funded company, having raised a total of $16M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4M, raised on Jul 2024.
Biostate was founded in 2023 in Houston, United States, as a developer of a generative AI platform focused on RNAstate research for bioinformatics. Temporal precision in predicting omics states is enabled through analytics, insights, and visualizations. Barcode-integrated reverse transcription is utilized to analyze RNA types, including non-coding species. Gene expression and regulation are examined via RNA sequencing tools, supporting insights into disease mechanisms and therapeutic targets for research organizations.
Biostate AI's top competitors include Cellworks, Codetta and Genuity Science.
Biostate AI offers Total RNASeq, mRNA Sequencing, and Data Analysis.
Biostate AI has 11 investors. Key investors include Caltech, Accel, Matter Venture Partners, Vision Plus Capital, and Catapult.
Biostate AI operates through Biostate Ai, Incorporated.